28 янв. 2023 г. · AbbVie and its affiliates have applied for 311 patents, of which 165 have been granted, related to Humira, according to the Initiative for ...

8 февр. 2023 г. · Since its original patent approval, AbbVie obtained or applied for 250 patents for Humira.

17 мар. 2022 г. · All told, AbbVie filed about 250 patent applications for Humira in the U.S., 90% of them following the drug's 2002 approval, according to the ...

Humira's 247 patent applications in the U.S. more than triple those in Europe, and almost quadruple those in Japan. If Humira were a standalone company, it ...

19 февр. 2021 г. · There are more than 100 patents on Humira. Most companies are not in a position to pursue such a broad patent portfolio, said Brougher, adding ...

Key Findings · 257. patent applications and 130 granted patents · 39. years of monopoly from granted patents · 90%. patent applications filed after FDA approval.

8 авг. 2022 г. · The basic US patent for Humira expired in 2016, but AbbVie, its owner, obtained 132 additional patents relating to the drug, the last of which ...

11 окт. 2022 г. · AbbVie applied for approximately 247 patents, of which 132 were granted, creating a “patent thicket” protecting Humira from competition until 2037.

14 дек. 2022 г. · Humira, for instance, has about 15 families of patents. If one of the patents is successfully disputed, perhaps the others in the family (which ...

21 мар. 2023 г. · Humira: lessons from 20 years of patents, pricing and profits.